TFRC and central nervous system cancer: For instance, researchers have developed bioengineered ferritin nanoparticles that can bind to transferrin receptor 1, which is overexpressed in blood-brain barrier endothelial cells.635 These nanoparticles are transported into the brain through transcytosis and achieve glioma-specific targeting by fusing different glioma-targeting moieties on the nanoparticles.